/주식/ICLR
ICLR

ICLR

USD

ICON plc Ordinary Shares

$146.690+2.270 (1.572%)

실시간 가격

Healthcare
Diagnostics & Research
아일랜드

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$144.420

고가

$148.310

저가

$142.640

거래량

1.28M

기업 기본 정보

시가총액

11.7B

산업

Diagnostics & Research

국가

Ireland

거래 통계

평균 거래량

1.49M

거래소

NMS

통화

USD

52주 범위

저가 $125.1현재가 $146.690고가 $347.72

관련 뉴스

PR Newswire

ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company...

더 보기
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
PR Newswire

ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company...

더 보기
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
BusinessWire

ICON plc to Present at the William Blair 45th Annual Growth Stock Conference

ICON plc, (NASDAQ:ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the William Blair 45th Annual Growth

더 보기
ICON plc to Present at the William Blair 45th Annual Growth Stock Conference
PR Newswire

ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company...

더 보기
ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm
BusinessWire

ICON releases its ICON Cares 2024 Report

ICON plc, (NASDAQ:ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today releases its ICON Cares 2024 Report. The report outlines how the company is delivering on its

더 보기
ICON releases its ICON Cares 2024 Report
PR Newswire

ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ICON Public Limited Company...

Analyst Upgrades

Mizuho Maintains Outperform on Icon, Lowers Price Target to $173

Mizuho analyst Ann Hynes maintains Icon with a Outperform and lowers the price target from $200 to $173.